Sex Hormones Flashcards
Ethinyl estradiol
Oral contraceptive, hormone replacement therapy, hypogonadism
MOA: Replaces Estrogen
Conjugated equine estrogens
Hormone replacement therapy
Tansdermal estradiol
Hormone replacement therapy or contraception; Replaces estrogen w/o first pass metabolism
Estradiol cypionate and estradiol valerate
Used for IM injections; replaces estrogen w/o first pass metabolism
Progestins
MOA: Feedback inhibition prevents ovulation and thickening of cervical mucous, atrophy of endometrium
Hirsutism (less common w/ newer agents), acne, wt gain, possible glucose intolerance, decreased HDL and increases LDL, breakthrough bleeding (progestin only), depression
p450 inducers can enhance elimination, enterohepatic metab interference can enhance elimination
Estrogen
Feedback inhibition prevents ovulation
Nausea, breast tenderness, increased skin pigmentation, migraine, inc coagulation, hypertension, breast cancer?, gallstones, elevate serum binding proteins, endometrial hyperplasia/cancer (if used w/o progestin in HRT)
p450 inducers can enhance elimination, enterohepatic metab interference can enhance elimination, increase bound estrogen thyroxine testosterone and iron (due to inc serum binding protein
Medroxyprogesterone acetate
used for IM injections (depo-provera); progesterone analogue
Medroxyprogesterone
Used in HRT; progesterone analogue
Norgestrel and levonorgestrel
Used in combination oral contraceptive, progestin only formulation, levo used for postcoital contraceptive
progesterone analogue, highest androgenic activity
Norethindrone
Combination OC, progestin only formulation
progesterone analogue; medium androgenic activity
Desogestrel
Combination OC
progesterone analogue; lowest androgenic activity
Not commonly used due to increased DVT risk
Drospirenone
Combination OC
progesterone analogue w/ anti-androgenic activity
Spironolactone derivative
Increased blood clots compared to standard contraceptives
Ulipristal Acetate
Postcoital contraceptive (effective 5 days after)
Progesterone receptor modulator (similar to RU-486)
Absolute contraindications for OC
Breast cancer or estr dependent neoplasia; abnormal genital bleeding; Hx of DVT or PE; Hx CVA or MI; Liver tumor; Heavy smoker after 35 y/o; Less than 6 weeks postpartum and breastfeeding